PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
-9.38%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+8%)
Cap. Flow
+$77.5M
Cap. Flow
% of AUM
20.49%
Top 10 Holdings %
Top 10 Hldgs %
65.17%
Holding
31
New
7
Increased
16
Reduced
2
Closed
6
Top Buys
| 1 |
Incyte
INCY
|
$18.6M |
| 2 |
Legend Biotech
LEGN
|
$16.2M |
| 3 |
Arvinas
ARVN
|
$15M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$14.3M |
| 5 |
United Therapeutics
UTHR
|
$13.6M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$23.4M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$15.6M |
| 3 |
argenx
ARGX
|
$14.7M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$13.3M |
| 5 |
Insmed
INSM
|
$10.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
argenx
ARGX
$43.6B
| – | – | -42,050 | Closed | -$14.7M |
|
27
Enanta Pharmaceuticals
ENTA
$180M
| – | – | -75,507 | Closed | -$5.65M |
|
28
Galapagos
GLPG
$2.07B
| – | – | -167,824 | Closed | -$9.25M |
|
|
29
Insmed
INSM
$28.8B
| – | – | -394,358 | Closed | -$10.7M |
|
|
SGEN
30
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – | -100,687 | Closed | -$15.6M |
|
|
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – | -251,777 | Closed | -$23.4M |
|